Home Forums Other Specialities Therapeutics Asthma- New treatment Addition

This topic contains 1 voice and has 0 replies.
1 voice
0 replies
  • Author
  • #2784

    Spiriva® Respimat® (tiotropium)

    is now indicated for add-on maintenance bronchodilator treatment in adults with asthma currently treated,

    with inhaled corticosteroids (at least 800 microgram daily of budesonide or equivalent) and long-acting ?2agonists and

    who experienced one or more severe exacerbations in the previous year.

    The soft-mist inhaler is already licensed for maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD).

    Do request if more info needed on this drug.

    G Mohan.

You must be logged in to reply to this topic.